Information disclosure, smoking and health protection. A critique of the European directive on the labelling of tobacco products

1998 ◽  
Vol 8 (3) ◽  
pp. 222-226
Author(s):  
T. Cutler
2018 ◽  
Vol 25 (1) ◽  
pp. 75-87
Author(s):  
Marco Inglese

Abstract Directive 2014/40/eu harmonises the manufacture, sales and presentation of tobacco and related products, notably, electronic cigarettes. As its predecessors, Directive 2014/40/eu has already been challenged on three occasions. This article will tackle the Pilbox case and assesses the impact of the principles of proportionality and subsidiarity on market harmonisation and health protection. It seeks to demonstrate that, contrary to the old-fashioned stream of case law on this subject, the battlefield has been shifted from the scope of Art. 114 tfeu to the impact of general principles of eu law. It then assesses how health protection increasingly permeates internal market legislations, leading to a sort of ‘paternalistic’ harmonisation. Finally, it argues that after two decades of disputes concerning tobacco products, the Court of Justice of the European Union (cjeu) has successfully ended litigations on Directive 2014/40/eu, holding that its compliance with the principles of proportionality and subsidiarity is beyond doubt.


Author(s):  
Kenneth F Warren

In this article I explore the history of cigar regulation, going back to colonial times, yet focusing on the current regulatory climate. I review the different regulations imposed on tobacco products throughout American history, concluding that government regulators were never particularly serious about regulating tobacco products until the release of the 1964 Surgeon General’s Report on Smoking and Health.  However, I point out that this Report was so obsessed with the health hazards of cigarettes that it actually had the unintended consequence of promoting In the long run the increased consumption of cigars. Today, health organizations show intense frustration with the FDA’s current refusal to regulate cigars, even though the 2009 Family Smoking Prevention and Tobacco Control Act gave the FDA regulatory jurisdiction over cigars. But applying a totality of circumstances test, looking at the politics, economics, and even the lack of enough credible health studies on cigars, I conclude, somewhat surprisingly, that there are very good reasons why the FDA should probably not at this time jump into the regulatory arena and impose the same sort of tough regulations on cigars as imposed on cigarettes.


Sign in / Sign up

Export Citation Format

Share Document